There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for 10x Genomics Inc. (TXG) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.33, or -0.69%, to $47.20. The 10x Genomics Inc. has recorded 9,096 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted 10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
As a NASDAQ listed company, TXG falls under the Healthcare sector while operating within the Health Information Services industry segment. At the end of the last regular session, the stock closed at $47.53 and fluctuated between $49.34 as its day high and $44.56 as its day low. The current market capitalization of 10x Genomics Inc. is $5.73B. A total of 0.87 million shares were traded on the day, compared to an average of 1.12M shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, TXG has seen 1 BUY and 0 SELL insider trades, representing the acquisition of 34,266 and the disposition of 0 shares. Over the last 12 months, there were 19 BUYs and 17 SELLs from insiders. Insiders purchased 345,330 shares during that period but sold 20,221.
In the most recent transaction, Saxonov Serge sold 1,941 shares of TXG for 47.75 per share on Feb 22. After the transaction, the Chief Executive Officer now owns 909,715 company shares. In a previous transaction on Feb 22, Hindson Benjamin J. sold 1,742 shares at 47.75 per share. TXG shares that insider owns now total 250,237.
Among the insiders who sold shares, McAnear Justin J. disposed of 1,245 shares on Feb 22 at a per-share price of $47.75. This resulted in the Chief Financial Officer holding 75,519 shares of TXG after the transaction. In another insider transaction, Saxonov Serge sold 2,676 shares at $34.07 per share on Nov 22. Company shares held by the Chief Executive Officer now total 974,926.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for TXG in the last 3 months, the mean price target is $52.60 with high estimates of $65.00 and low estimates of $25.00. In terms of 52-week highs and lows, TXG has a high of $83.34 and a low of $23.81.
As of this writing, TXG has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of -$0.22 per share and a lower estimate of -$0.39. The company reported an EPS of -$0.57 in the last quarter, which was -46.20% lower than expectations of -$0.39.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 12 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TXG is Hold with a score of 3.80. A total of 7 analysts rated the stock as Buy while 0 rated it as Overweight while 3 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 1 thought it should be Sold.